Delivery Order SPE2DB22D3011-SPE2DB25FP8ZT

Award Date 1/28/25
Potential Completion Date 1/29/25
Potential Value $28K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $6,275.18, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a delivery order under the company's existing $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, covers the supply of Cosentyx (300 mg dose) medication. The contract has a completion date of November 6, 2024 and utilizes a firm fixed-price pricing...
This federal contract award, valued at $1,648.59, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a delivery order for the pharmaceutical product Cosentyx, a specialty medication used to treat certain medical conditions. The contract has a fixed-price pricing type and an ultimate completion date of February 29, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract, valued at up to $4,779.26, is for the delivery of the drug Cosentyx in 300mg doses. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 with the DLA Troop Support Medical through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to supply a...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the supply of Cosentyx, a prescription medication. The contract is a Delivery Order with a Firm Fixed Price of $3,043.90 and has an Ultimate Completion Date of May 21, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. Under...
This federal contract award is for the delivery of the pharmaceutical product Cosentyx (300mg dose) to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The contract, valued at $3,512.84, was awarded to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the federal government. The contract is a Firm Fixed Price Delivery Order placed under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the supply of Cosentyx, a medication used to treat certain chronic conditions. The contract is a Delivery Order with a Firm Fixed Price of $9,514.34 and an Ultimate Completion Date of April 24, 2024. The contract does not have a Set-Aside designation. Amerisourcebergen Drug Corp is the prime contractor and holds a larger Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of the specialty medication Cosentyx (300 mg dose) under a Firm Fixed Price Delivery Order. The contract has an ultimate completion date of August 29, 2024 and a ceiling value of $10,581.93. This award is likely part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up...
This federal contract award, valued at $4,723.68, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the specialty medication Cosentyx (300mg dose) and has a completion date of January 17, 2025. This appears to be a specific delivery order against a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
This federal contract award, valued at $11,060.14, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the drug Cosentyx, a medication used to treat certain autoimmune conditions. The contract is a firm fixed-price delivery order with a completion date of January 14, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $3,043.92, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is a delivery order, is for the supply of Cosentyx, a specialty medication used for the treatment of various conditions. The contract is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen Drug Corp holds with the DLA Troop Support Medical, valued at up to...
  • SPE2DB22D3011
    Indefinite Delivery Contract
  • SPE2DB22D3011-SPE2DB25FP8ZT
    Delivery Order

This federal contract award, with the ID SPE2DB22D3011|SPE2DB25FP8ZT, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of the drug Cosentyx in 300mg doses, with a firm fixed-price of $28,072.67 and a completion date of January 29, 2025.

Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, including the military and veterans' healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award is not designated with any set-aside requirements, indicating open competition.

Generated 5/4/25, 1:00 AM